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Abstract – Palladium or copper catalyzed aminations or amidations were performed to obtain diarylamines and 
diarylacetamides precursors of thienocarbazoles. The fact that an ortho-bromodiarylamine didn’t cyclize to the 
corresponding thienocarbazole under conditions known for carbazoles from ortho-halodiphenylamines, conducted us to 
a highgly efficient method of palladium-catalyzed intramolecular cyclisation with N-deprotection of ortho-
halodiarylacetamides to thienocarbazoles. Other method of intramolecular cyclization of diarylamines based on the 
reoxidation of the Pd(0) formed by Cu(OAc)2 , avoiding the use of stoichiometric amounts of Pd(OAc)2, gave 
thienocarbazoles in a moderate yield, including a ring A methoxylated compound. An attempt to combine palladium 
and copper catalyses in a “one pot” reaction of amination and intramolecular cyclization gave as major product a N-
benzo[b]thiophene substituted carbazole and the required thienocarbazole in low yield. 
 
 
1. Introduction 
 
Due to their interesting biological activities carbazole alkaloids constitute an important class of 
natural compounds.1 Their isolation from different sources (terrestrial plants, marine sources and 
streptomycetes) induced the development of novel strategies of synthesis of structurally 
unprecedent carbazole derivatives.2 Heteroannellated carbazoles are often of potential biological 
interest, mostly based on their special affinity to DNA. Therefore this type of compounds play a 
crucial role as potential leads for the discovery of antitumor active drugs.3 
One of the standard methodologies that the medicinal chemist can use as a rational approach to lead 
optimisation is the bioisosteric replacement.4,5 Bioisosteres are substituents or groups, that do not 
necessarily have the same size or volume, but have a similarity in chemical or physical properties 
which could produce broadly similar biological properties but being expected significant changes in 
selectivity, toxicity and metabolic stability. However there are many examples where bioisosteric 
replacements have resulted in marked increases in potency as well as efficacy. The use of classical 
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isosteres as benzene, thiophene and pyridine resulted in analogues with biological activity retention 
among different series of pharmacological agents.5 Thus thienocarbazoles I are bioisosteric 
analogues of the known natural antitumoral pyridocarbazoles, ellipticines IIa-c and olivacine IId, 
by substitution of the pyridine ring by a thiophene and are being prepared to evaluate their 
biological activity either as DNA intercalating compounds, interacting or not with Topoisomerase 
II, or as radical scavengers compounds.6 The achievement of less toxic compounds than 
pyridocarbazoles is also a very important goal. 
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The sulfur atom can provide interesting properties to this type of molecules like the establishement 
of additional long distance hydrogen bonds with the DNA chains or even confer to the molecule 
interesting photochemical properties for use as markers or in phototherapy applications.7, 8 Some 
preliminary studies of fluorescence of our new molecules have already begun. 
The methyl groups and their position on the bioactive pyridocarbazoles showed to be important for 
the antitumor activity.9 Ring A substitution had also proven to be very important for the activity 
being 9-methoxy and 9-hydroxyellipticines IIb and c much more active than ellipticine IIa.10 
In recent years we have been interested in finding a ring B method for the synthesis of substituted 
linear and angular thienocarbazoles, in order to evaluate their structure-activity relationship. The 
angularity or the linearity of the molecules, the position of the methyl groups, together with the 
introduction of ring A substituents, namely groups that increase water solubility and/or activity, are 
important features for biological devices.  
Some convergent ring B methods have already been envisaged by us for the synthesis of several 
methylated thienocarbazoles but the yields were either too low from diarylamines 11,12 or fair to 
moderate from nitrodiaryl compounds.13  
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In this paper we report a high efficient palladium-catalyzed cyclization with deprotection of ortho-
halodiarylamides, prepared by copper-catalyzed Goldberg coupling, 11 to the corresponding novel 
thieno[3,2-c]carbazole. This method enables the synthesis of differently substituted hiherto linear 
and angular thienocarbazoles from appropriated precursors. 
Other method of cyclization based in the reoxidation of Pd(0) by Cu(OAc)214, avoiding the use of a 
stoichiometric amount of Pd (OAc)2 in the oxidative cyclization of diarylamines gave also rise to 
the corresponding thieno[3,2-c]carbazoles, including a ring A methoxylated, in a moderate yield. 
The diarylamines were prepared either by hydrolysis of diarylacetamides or by palladium catalyzed 
amination of aryl halides under Buchwald’s conditions.15 An ortho-bromodiarylamine obtained 
using the latter conditions, didn’t cyclise to the corresponding thienocarbazole under the 
Sakamoto’s cyclisation conditions.16 
 
2.Results and discussion 
 
 
2.1. Synthesis of an ortho-bromodiarylamine under Buchwald’s conditions and attempted 
intramolecular cyclisation  
 
  
First it was decided to couple ortho-haloanilines 1a and 1b with 6-bromobenzo[b]thiophene 2 17 or 
2-bromo-iodobenzene with 6-aminobenzo[b]thiophene 3 under Buchwald’s conditions 15 to obtain 
ortho-halodiarylamines. Some modifications such as the use of higher amounts of Pd(OAc)2 (3 
mol%) and BINAP (4 mol%) comparing to those used in literature 15 were needed in our case, may 
be due to some complexation of the palladium by the sulfur atom. Bromobenzo[b]thiophene 2 gave 
20% yield of o-bromodiarylamine 4 in the coupling with o-bromoaniline (Scheme 1). When o-
bromo-iodobenzene was reacted with aminobenzothiophene 3, the yield was increased to 40% in 
one third of the reaction time. The reactions were followed by TLC and stopped when the formation 
of the product seemed not to increase. In both cases the starting materials were recovered. Under the 
same conditions no iodo diarylamine 5 could be prepared from compounds 1b and 2, occurring 
decomposition of the aniline.  
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Scheme 1. Synthesis of o-bromodiarylamine 4 by palladium catalyzed amination of arylhalides
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The use of Pd2(dba)3 and DPPF, as described for the preparation of ortho-halodiphenylamines 
precursors of carbazole,16 was not effective in our case. 
The amine 3 was obtained under drastic basic conditions 18 from the corresponding steric hindered 
acetamide 6 which was prepared by Beckmann rearrangement of the oxime of 6-acetylated 
compound 19 (Scheme 2). 
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Attempts to perform the C-N coupling using the acetamide 6 under Buchwald’s conditions were 
unsuccessfull.  
When the ortho-bromodiarylamine 4 was submitted to Sakamoto’s intramolecular cyclization 
conditions, that have worked to obtain carbazoles from ortho-bromodiphenylamine,16 
 5
thienocarbazole 7 did not form (Scheme 3). Changing the base to NEt3 no thienocarbazole was 
obtained either.  
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Scheme 3. Attempted intramolecular cyclization by Sakamoto's conditions  
 
2.2. Synthesis of ortho-halodiarylamides by Goldberg coupling and intramolecular 
cyclisation  
 
The latter unsuccessful result led us to try our Goldberg coupling conditions,11 reacting acetamide 6 
with 2-bromo-iodobenzene using 30 mol% of Cu2O, K2CO3, heating without solvent at 180 oC. A 
mixture of acetamides 8a and 8b (~ 40% yield) was obtained and it was impossible to separate the 
compounds by chromatography, being characterized by mass spectrometry. Along with amides 8a 
and 8b the dehalogenated amide 9 was isolated in 8% yield (Scheme 4). The use of a stoichiometric 
amount of Cu2O didn’t increase significatively the yield for amides 8a,b and the yield for amide 9, 
as a by-product was not altered.  
N
R
X
S
I SHN
Br
COMe
N
R
S
+
8a R=COMe, X=Br
8b R=COMe, X=I
+
9R=COMe
4 R=H, X=Br
5 R=H, X=I
ii
10 R=H
ii
6
i)Cu2O(30mol%), K2CO3, 180 
oC, 12h ; ii)  NaOH (10equiv.), ethylene glycol 1h reflux
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Due to the hindered rotation around the amide bond in 8, 1H-NMR spectra of these compounds 
reveal several sets of signals and could not be used for structure assignment. Thus, the amides 8 
were converted to amines 4 and 5, obtained also as a mixture (~ 75% yield), using drastic basic 
conditions17 in gently refluxing ethylene glycol (silicone bath at 200 oC) (Scheme 4). 
Iododiarylamine 5 was characterized by 1H-NMR excluding the proton signals of amine 4 already 
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prepared by palladium catalysis (Scheme 1). The structure of amine 5 was also confirmed 
deprotecting the amide 8b independently obtained (30% yield) from Goldberg coupling ( soich. 
Cu2O) of 1,2-di-iodobenzene and amide 6. The same reaction was also performed using the much 
less expensive 1,2-dibromobenzene and 6 to give amide 8a (30% yield) which was submitted to 
Sakamoto’s cyclization conditions to afford thienocarbazole 7 in high yield.. 
Amide 9 showed also hindered rotation in the 1H-NMR spectrum giving after deprotection, in the 
same conditions, the corresponding amine 10 (Scheme 4). Amide 9 was independently synthesized 
in high yield using the Goldberg coupling reaction and a stoichiometric amount of Cu2O as outlined 
in Scheme 5. 
 
Br
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Scheme 5. Golbberg coupling to obtain amide 9  
 
Deprotection of 8a and 8b with NaOH in a vigourous refluxing ethylene glycol (silicone bath at 220 
oC), resulted in the formation of 10 in 50% yield, together with the ortho-bromodiarylamine 4 in 
10% yield and the thienocarbazole 7 in 5% yield (Scheme 6). In another experiment increasing the 
time of reflux in these conditions, the proportions of the three products did not change. The 
formation of thienocarbazole 7 in these conditions indicates that a strong basic medium submitted to 
a high temperature induces in a small extent the cyclization reaction, possibly through a benzyne 
intermediate. 
 
8a and 8b
i
i) NaOH (10equiv.), ethylene glycol, 1h vigorous reflux
4 (10% ) + 10 (50% ) +  7 ( 5% )
Scheme 6. Drastic basic conditions in ethylene glycol vigorous refluxing  
 
While Sakamoto’s cyclization conditions have only been used with o-halodiarylamines, we decided 
to use them with the mixture of o-haloacetamides 8a and 8b. Surprisly the thienocarbazole 7 was 
obtained with N-deprotection, in quantitative yield (Scheme 7). A control experiment performed in 
the same conditions without the palladium catalyst, did not provide the thienocarbazole 7. 
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Scheme 7. High efficient synthesis of thienocarbazole 7  
 
2.3. Intramolecular cyclisation of diarylamines using Pd(OAc)2 and Cu(OAc)2 
 
Cyclization of the dehalogenated acetamide 9 to thienocarbazole 7 didn’t occur when the same 
conditions were used, but the corresponding amine 10 gave the thienocarbazole 7 in 30% yield 
when treated with palladium acetate (50mol%) and copper acetate (3equiv.) in acetic acid at 120 oC, 
(Scheme 8). The role of Cu(OAc)2 is the reoxidation of the Pd(0) formed after electrophilic attack of 
Pd(OAc)2 on the aromatic rings, avoiding the use of a stoichiometric amount of this reagent.14 
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Scheme 8.Cyclization of diarylamine 10 to thienocarbazole 7  
 
This also constitutes a valuable method for the synthesis of thienocarbazoles that will be applied to 
diarylamines prepared either by N-deprotection of diarylacetamides or by palladium catalysed 
amination of arylhalides. As an example, the methoxydiarylamine 11 was prepared in 60 % yield, 
coupling the arylhalide 2 with 4-methoxyaniline under Buchwald’s conditions and then cyclized to 
the corresponding methoxylated thieno[3,2-c]carbazole 12 in 30% yield in the same oxidative 
conditions (Scheme 9). 
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2.4. “One pot“ procedure of C-N coupling and intramolecular cyclisation combining copper 
and palladium catalyses  
 
A “one pot” procedure attempt to obtain the thienocarbazole 7, combining copper and palladium 
catalyses, reacting amine 3 with 2-bromo-iodobenzene in reflux of DMF for 10 h, gave the N-
benzo[b]thiophene substituted carbazole 13 (M+ 341) as major product in 30% yield and the 
thienocarbazole 7 only in 10% yield (Scheme 11). Lowering the time of heating the two products 
were obtained in the same proportion. 
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Scheme 10. "One pot" procedure to carbazole 13 and thienocarbazole 7
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The formation of a dihalogenated intermediate 14 before cyclization to carbazole 13, is in 
agreement with the synthesis of N-methylsulfonylcarbazole from N-methylsulfonyl-o,o´-
dibromodiphenylamine.16  
N
S
14
X X
X=Br or I  
 
The same “one pot” conditions were not successful when applied to acetamide 6 and 2-bromo-
iodobenzene, resulting in extensive decomposition. 
 
3.Conclusion 
 
Novel synthetic routes to thienocarbazoles based on the combination of metal assisted C-N 
coupling and intramolecular cyclisations were described. The target compounds could act as DNA-
binding agents which may be used as biological or medical relevant probes or drugs. These methods 
will be applied to the preparation of linear and angular methylated thienocarbazoles substituted in 
ring A by electron donating or withdrawing groups, for evaluation of their biological activity and 
structure activity relationship.  
 
4.Experimental 
 
4.1. Materials and methods 
Melting points (oC) were determined in a Gallenkamp apparatus and are uncorrected. IR spectra 
were recorded as nujol mulls on a Perkin-Elmer 1600-FTIR spectrophotometer and wavenumbers 
are given in cm-1. 1H and 13C NMR spectra were recorded on a Varian Unity Plus (300 and 75,4 
MHz respectively). 1H-1H spin-spin decoupling and DEPT θ 45º were used. Chemical shifts are 
given in ppm and coupling constants in Hz. The mass spectra were obtained on a Unicam GC/MS 
120 spectrometer or on a Micromass Autospec 3F by an electronic impact (70eV) direct injection 
method. Elemental analysis was performed on a LECO CHNS 932 elemental analyser. 
The reactions were monitered by thin layer chromatography (TLC). Column chromatography was 
performed on Macherey-Nagel silica gel 230-400 mesh. Preparative Layer Chromatography (PLC) 
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was performed in 20x20cm plates Macherey-Nagel, Layer 2mm SIL G-200 UV254. Petroleum ether 
refers to the boiling range 40-60 oC. Ether refers to diethylether. When solvent gradient was used, 
the increase of polarity was made gradually from petroleum ether to mixtures of ether/petroleum 
ether increasing 10% of ether until the isolation of the product.  
 
4.2. Synthesis of 6-Acetamido-2,3,5-trimethylbenzo[b]thiophene (6): To hydroxylamine 
hydrochloride (8.30 g, 119 mmol) in 13 ml of water, a solution of NaOH (3.50 g, 87.5 mmol) in 12 
ml of water was added with external cooling. 6-Acetyl-2,3,5-trimethylbenzo[b]thiophene 19 (12.5 g, 
57.0 mmol) was then added in a sufficient amount of ethanol to promote a homogeneous solution, 
which was heated at reflux for 1 h 30 min. After cooling the precipitate formed was filtered and 
dried at 60 oC. The colourless solid obtained showed to be the corresponding oxime (10.6 g, 80%) 
m.p. 191-193 (lit19 191, from petroleum ether). 1H NMR: (CDCl3): 2.26 (3H, s, Me), 2.28 (3H, s, 
Me), 2.46 (3H, s, Me), 2.50 (3H, s, Me), 7.41 (1H, s, H-7), 7.60 (1H, s, H-4). MS: 233 (100, M+) 
218 (78) 201 (82). To the oxime (6.00 g, 25.7 mmol) in dry ether (150 ml) PCl5 (6.00 g, 28.6 mmol) 
was added and the mixture was left stirring for 30 min. The ether was removed and water was 
added. The aqueous mixture was heated at reflux for 1h 30min and after cooling the colourless 
precipitate formed was filtered, dried and showed to be the amide 6 (4.00 g, 67%), m.p. 188-190. 
IR: 3237 (N-H), 1651 (C=O). 1H NMR: ([D6]DMSO) 2.08 (3H, s, Me), 2.23 (3H, s, Me), 2.31 (3H, 
s, Me), 2.43 (3H, s, Me), 7.47 (1H, s, H-4), 7.85 (1H, s, H-7), 9.33 (1H, s, N-H).13C NMR: 
([D6]DMSO) 11.10 (CH3), 13.49 (CH3), 18.19 (CH3), 23.31 (NCOCH3), 117.92, 122.06, 126.28 
(C), 128.32 (C), 132.88 (C), 133.06 (C), 134.65 (C), 138.07 (C), 168.35 (C). MS: 233 (73, M+), 191 
(100), 190 (53), 176 (41). Anal. calcd for C13H15NOS:. C 66.92, H 6.48, N 6.00, S 13.74 %; found: 
C 66.79, H 6.23, N 5.94, S 13.72.  
 
4.3. General procedure for the synthesis of diarylamines 4 and 11 under Buchwald’s 
conditions: A dry Schlenk tube was charged under Ar with dry toluene (3-4 ml), the arylhalide, the 
arylamine, t-BuONa (1.4 equiv.), Pd(OAc)2 (3 mol%), racemic BINAP (4 mol%) and the mixture 
was heated at 90 oC for several hours. The reaction was followed by TLC. After cooling water and 
ether were added. The organic phase was separated, dried (MgSO4) and solvent removed to give an 
oil which was submitted to chromatographic purification to give the product and  starting materials. 
 
4.3.1. 6-(2-Bromophenyl)amino-2,3,5-trimethylbenzo[b]thiophene (4): From arylhalide 2 17 
(0.510 g, 2.00 mmol) and bromoaniline 1a (0.430 g, 2.50 mmol) heating for 70 h and column 
chromagraphy using petroleum ether, the arylhalide 2 was recovered in 57% yield as the less polar 
product, compound 4 was obtained in 20% yield as a white solid, m.p.126-128. IR: 3377 (N-H). 1H 
NMR: (CDCl3) 2.29 (3H, s, Me), 2.37 (3H, s, Me), 2.47 (3H, s, Me), 5.96 (1H, s, N-H), 6.69 (1H, 
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oct, J = 7.93, 7 and 1.5, H-4’), 6.81 (1H, dd, J = 8.24 and 1.5, H-6’), 7.11 (1H, sept, J = 8.24, 7 and 
1.5, H-5'), 7.46 (1H, s, H-7), 7.52 (1H, dd, J = 7.93 and 1.5, H-3’), 7.61 (1H, s, H-4). 13C NMR: 
(CDCl3) 11.37 (CH3), 13.76 (CH3), 18.33 (CH3), 110.94 (C), 114.70, 116.45, 119.75, 122.84, 
126.44, 128.19, 128.99 (C), 132.69, 133.02 (C), 136.11 (C), 136.38 (C), 138.31 (C), 142.90 (C). 
Anal. calcd for C17H16BrNS: C 58.97, H 4.66, N 4.04, S 9.26; found: C 58.71, H 4.77, N 3.91, S 
9.31.  
From 2-bromo-iodobenzene (0.185 g, 0.650 mmol) and arylamine 3 (0.100 g, 0.500 mmol) heating 
for 21 h, compound 4 was obtained in 40% yield after column chromatography.  
 
4.3.2. 6-(4-Methoxyphenyl)amino-2,3,5-trimethylbenzo[b]thiophene (11): From arylhalide 2 
(0.240 g, 2.00 mmol) and 4-methoxyaniline (0.500 g, 2.00 mmol), heating for 24 h, and using 
solvent gradient from petroleum ether to 30% ether/petroleum ether in the chromatographic 
purification, compound 11 was obtained as a white solid (0.350 g, 60%), m.p. 127-129, which after 
crystallization from ether/petroleum ether gave white crystals m.p. 130-132. IR: 3394 (N-H). 1H 
NMR: ([D6]DMSO) 2.19 (3H, s, Me), 2.29 (3H, s, Me), 2.36 (3H, s, Me), 3.70 (3H, s, OMe), 6.84 
(2H, d, J = 9, H-3’ and 5’), 6.94 (2H, d, J = 9, H-2’ and 6’), 7.03 (1H, s, H-7), 7.28 (1H, s, H-4), 
7.38 (1H, s, N-H). 13C NMR: ([D6]DMSO) 11.12 (CH3), 13.31 (CH3), 18.39 (CH3), 55.19 (OCH3), 
108.52, 114.53, 120.18, 122.66, 125.01 (C), 126.15 (C), 129.59 (C), 134.54 (C), 135.83 (C), 137.62 
(C), 140.73 (C), 153.54 (C). Anal. calcd for C18H19NOS: C 72.70, H 6.44, N 4.71, S 10.78; found: 
C 73.00, H 6.27, N 4.78, S 10.70.  
 
4.4. Goldberg coupling 
 
4.4.1 6-(2-Bromophenyl)acetamido-2,3,5-trimethylbenzo[b]thiophene (8a), 6-(2-
iodophenyl)acetamido-2,3,5-trimethylbenzo[b]thiophene (8b) and 6-(phenyl)acetamido-2,3,5-
trimethylbenzo[b]thiophene (9): A mixture of the acetamide 6 (1.00 g, 4.30 mmol), 2-bromo-
iodobenzene (1.80 g, 6.40 mmol), K2CO3 (0.600 g, 4.30 mmol), Cu2O (0.190 g, 1.33 mmol) was 
heated at 180 oC for 12 h. After cooling chloroform was added and the mixture was filtered. The 
filtrate was evaporated to give a brown oil which was submitted to column chromatography using 
solvent gradient from petroleum ether to 50% ether/petroleum ether. As the less polar product, the 
dehalogenated amide 9 was obtained as a white solid (0.100 g, 8%), m.p. 212-214. IR: 1675 (C=O). 
1H NMR spectra in CDCl3 or in [D6]DMSO at several temperatures showed hindered rotation, 
being this compound identified by the 1H NMR spectrum of the corresponding amine 10 (see 
below). MS: 312 (8, M++2), 311 (20, M++1,), 310 (100, M+). Anal. calcd for C19H19NOS: C 73.75, 
H 6.19, N 4.53, S 10.36; found: C 73.45, H 6.37, N 4.74, S 10.34.  
 12
Another fraction was isolated as a yellow light solid and showed to be a mixture of 8a and 8b 
(0.650 g, ~ 40%), m.p. 148-150. 1H NMR spectra in CDCl3 or in [D6]DMSO at several 
temperatures showed hindered rotation, being the characterization done by the obtention of the 
corresponding amines 4 and 5 (see below). MS: 436 (100, M+ of 8b, 100), 390 (30, M+  81Br of 8a), 
388 (30, M+ 79Br of 8a). 
 
4.4.2. 6-(phenyl)acetamido-2,3,5-trimethylbenzo[b]thiophene (9): A mixture of the acetamide 6 
(0.215 g, 0.920 mmol), 2-bromobenzene (0.174 g, 1.10 mmol), K2CO3 (0.320 g, 2.30 mmol), Cu2O 
(0.130 g, 0.920 mmol) was heated at 180 oC for 8 h. After cooling chloroform was added and the 
mixture was filtered. The filtrate was evaporated to give a brown oil which was submitted to 
column chromatography using solvent gradient from petroleum ether to 10% ether/petroleum ether 
to give amide 9 as a white solid (0.240 g, 84%) with identical properties to those presented above.  
 
4.5. General procedure of deprotection of acetamides 6, 8a,b and 9: A solution of the acetamide 
and sodium hydroxide (10 equiv.) in ethylene glycol was heated at reflux (silicone bath at 200 oC). 
After cooling, the mixture was poured into iced water  and after stirring, extracted with ether. The 
organic phase was dried (MgSO4), filtered and the solvent removed to give  an oil which was 
submitted to chromatographic purification or to crystallization. 
 
4.5.1. 6-Amino-2,3,5-trimethylbenzo[b]thiophene (3): Acetamide 6 (0.700 g, 3.00 mmol), NaOH 
(1.20 g, 30.0 mmol) in ethylene glycol (5 ml) were heated for 3 h. Chromatographic column using 
solvent gradient from petroleum ether to 50% ether/petroleum ether, gave the amine 3 as a 
colourless solid (0.357 g, 51%), m.p. 96-98. IR: 3423 (N-H). 1H NMR: (CDCl3) 2.22 (3H, s, Me), 
2.30 (3H, s, Me), 2.41 (3H, s, Me), 3.60 (1H, s, N-H), 7.04 (1H, s, H-7), 7.26 (1H, s, H-4).13C 
NMR: (CDCl3) 11.37 (CH3), 13.54 (CH3), 17.90 (CH3), 106.99, 120.70 (C), 122.35, 126.25 (C), 
129.12 (C), 134.16 (C), 137.03 (C), 141.60 (C). Anal. calcd for C11H13NS: C 69.07, H 6.85, N 7,32, 
S 16.76; found: C 68.96, H 6.89, N 7.25, S 16.57.  
 
4.5.2. 6-(2-Bromophenyl)amino-2,3,5-trimethylbenzo[b]thiophene (4) and  
6-(2-iodophenyl)amino-2,3,5-trimethylbenzo[b]thiophene (5): A mixture of acetamides 8a and 
8b (0.200 g, ~ 0.460 mmol)) and sodium hydroxide (0.184 g, 4.60 mmol) ) in ethylene glycol (5 ml) 
was refluxed for 1 h. After column chromatography using solvent gradient from petroleum ether to 
30% ether/ petroleum ether, a white solid was obtained (~ 75%) which 1H NMR spectrum showed 
to be a mixture of amines 4 and 5 being 5 in a slightly excess. 1H NMR: (CDCl3) 2.29 (2x3H, s, 
2xMe of 4 and 5), 2.37 (2x3H, s, 2xMe of 4 and 5), 2.47 (2x3H, s, 2xMe of 4 and 5), 5.82 (1H, s, 
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N-H of 5), 5.96 (1H, s, N-H of 4), 6.57 (1H, oct, J = 7.93, 7 and 1.5, H-4’ of 5), 6.69 (1H, oct, J = 
7.93, 7 and 1.5, H-4’ of 4), 6.77 (1H, dd, J = 8.24 and 1.5, H-6’ of 5), 6.81 (1H, dd, J = 8.24 and 
1.5, H-6’ of 4), 7.11 (1H, sept partially obscured, J = 8.24, 7 and 1.5, H-5' of 4), 7.14 (1H, sept 
partially obscured, J = 8.24, 7 and 1.5, H-5' of 5) 7.46 (2x1H, s, 2x H-7 of 4 and 5), 7.52 (1H, dd, J 
= 7.93 and 1.5, H-3’ of 4), 7.60 (1H, s, 2x H-4 of 4 and 5), 7.77 (1H, dd, J = 7.93 and 1.5, H-3’ of 
5).  
The signals of compound 4 were later confirmed from the deprotection of amide 8b, independently 
obtained from the Goldberg coupling of 1,2-di-iodobenzene and amide 6 (see section 2.2). 
 
4.5.3. 6-(Phenyl)amino-2,3,5-trimethylbenzo[b]thiophene (10):  A mixture of amide 9 (0.100 g, 
0.323 mmol) and sodium hydroxide (0.130 g, 3.20 mmol) in ethylene glycol (5 ml) was refluxed for 
1 h. The oil obtained was crystallized from ether/petroleum ether to give colourless crystals (70.0 
mg, 75%), m.p. 138-140. IR: 3384 (N-H). 1H NMR: (CDCl3) 2.27 (3H, s, Me), 2.37 (3H, s, Me), 
2.45 (3H, s, Me), 5.45 (1H, s, N-H), 6.93 (2H, m, Ar-H), 7.26 (2H, m, Ar-H), 7.41 (1H, s, H-7), 
7.60 (1H, s, H-4). 13C NMR: (CDCl3) δ  11.37 (CH3), 13.70 (CH3), 18.40 (CH3), 112.69, 116.90, 
120.13, 122.72, 126.37 (C), 126.55 (C), 129.34, 131.79 (C), 136.54 (C), 136.79 (C), 137.87 (C), 
144.62 (C). Anal. calcd for C17H17NS: C 76.36, H 6.41, N 5.24, S 11.99; found: C 76.55, H 6.21, N 
4.91, S 11.71.  
 
4.6. Palladium-catalyzed cyclization with deprotection of acetamides 8a,b 
 
4.6.1. 2,3,5-Trimethyl-6H-thieno-[3,2-c]carbazole (7): The mixture of amides 8a and 8b (0.150 g, 
~ 0.350 mmol), Na2CO3 (57.0 mg, 0.540 mmol) and Pd(OAc)2 (10 mol%) in refluxing DMF (5 ml) 
were heated for 7 h. After cooling, ethyl acetate (20 ml) and water (30 ml) were added. The phases 
were separated and the aqueous phase was extracted with ethyl acetate (2 x 10 ml). The organic 
phase was dried and filtered. Removal of the solvent left a brown residue (0.130 g) which was 
submitted to PLC (50% ether/petroleum ether) to afford the product as a white solid (83.0 mg, 
quantitative yield), m.p. 215-217. IR: 3411 (N-H). 1H NMR: (CDCl3) 2.40 (3H, s, Me), 2.59 (3H, s, 
Me), 2.69 (3H, s, Me), 7.35 (1H, td, J = 8 and 1.2, H-9), 7.46 (1H, td, J = 8 and 1.2, H-8), 7.48 (1H, 
s, H-4), 7.55 (1H, broad d, J = 8, H-7), 8.14 (1H, s, N-H), 8.16 (1H, broad d, J = 8, H-10). 13C 
NMR: (CDCl3) 11.74 (CH3), 13.75 (CH3), 17.16 (CH3), 110.66, 116.05 (C), 117.07 (C), 119.57 (C), 
119.78, 121.56, 122.91 (C), 125.00, 126.98 (C), 128.54 (C), 129.72 (C), 135.02 (C), 136.50 (C), 
138.97 (C). Anal. calcd for C17H15NS: C 76.94, H 5.70, N 5.30, S 12.08; found: C 76.69, H 5.45,  N 
5.16, S 12.01. 
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4.7. General procedure for intramolecular cyclization of non ortho-halogenated amines 10 and 
11: A mixture of  the diarylamine, Pd(OAc)2 (0.5 equiv), Cu(OAc)2 (3 equiv) and glacial acetic acid 
was heated at 120 ºC for 7 h. After cooling, ether (15 ml) and water (10 ml) were  added. The 
phases were separated and the organic phase was washed with water, dried (MgSO4) and filtered. 
Solvent removal gave an oil which was submitted to P.L.C 50% ether/petroleum ether to afford  the 
product. Starting material was recovered. 
 
4.7.1. Thienocarbazole (7): From amine 10 (0.170 g, 0.640 mmol), in glacial acetic acid (4 ml), 
thienocarbazole 7 was obtained as a white solid (50.0 mg, 30%), which showed identical properties 
to those presented above. 
 
4.7.2. 9-Methoxy-2,3,5-trimethyl-6H-thieno[3,2-c]carbazole (12): From amine 11 (0.140 mg, 
0.470 mmol) in glacial acetic acid (5 ml), thienocarbazole 12 was obtained as a light yellow solid 
(40.0 mg, 30%), giving colourless crystals from ether/petroleum ether cristalization m.p. 201-203. 
IR: 3378 (N-H). 1H NMR: (CDCl3) 2.40 (3H, s, Me), 2.59 (3H, s, Me), 2.67 (3H, s, Me), 4.01 (3H, 
s, OMe), 7.10 (1H, dd, J = 8.7 and 2.4, H-8), 7.44 (2H, broad d, J = 8.7, H-7 and H-4 obscured), 
7.62 (d, 1H, J = 2.4, H-10), 8.01 (1H, s, N-H). 13C NMR: (CDCl3) 11.78 (CH3), 13.76 (CH3), 17.19 
(CH3), 56.06 (OCH3), 104.14, 111.38, 114.30, 116.06 (C), 117.26 (C), 119.52, 123.27 (C), 127.03 
(C), 128.42 (C), 129.44 (C), 133.88 (C), 134.65 (C), 137.31 (C), 154.13 (C). MS: 295 (100, M+), 
280 (37, M+-15). HRMS C18H17NOS: caldt. M+  295.10307; found 295.10339. 
 
4.8 Synthesis of N-[6-(2,3,5-trimethylbenzo[b]thiophene)]carbazole (13): Amine 3 (0.270 g, 1.40 
mmol), 2-bromo-iodobenzene (0.410 g, 1.40 mmol), Pd(OAc)2 (10 mol%), Cu2O (20 mol%), 
K2CO3 (2.5 equiv) in dimethylformamide (10 ml) were heated at reflux for 10 h 30 min. After 
cooling, water and ether were added and the organic phase was separated, washed with water,  dried 
(MgSO4) and filtered. Removal of solvent left a brown solid (0.240 g) which was submitted to 
P.L.C., 50% ether/petroleum ether giving as the less polar product the N-substituted carbazole 13 as 
a light yellow solid (0.140 g, 30%), m.p. 187-189. 1H NMR: (CDCl3) 2.05 (3H, s, Me), 2.40 (3H, s, 
Me), 2.56 (3H, s, Me), 7.06 (broad 2H, d, J = 8, H-1 and 8), 7.30 (2H, td, J = 8 and 1.2, H-3 and 6), 
7.40 (2H, td,  J = 8 and 1.2, H-2 and 7), 7.67 (1H, s, H-7’), 7.76 (1H, s, H-4’), 8.19 (2H, broad d, J 
= 8, H-4 and 5).13C NMR: (CDCl3) 11.50 (CH3), 13.99 (CH3), 17.82 (CH3), 109.80, 119.46, 120.28, 
122.69, 122.94 (C), 123.14, 123.27, 125.86, 126.67 (C), 127.20, 132.15 (C), 133.14 (C), 135.67 
(C), 136.27 (C), 141.50 (C), 141.56 (C). MS: 341 (100, M+). HRMS C23H19NS: caldt. M+  
341.123822, found 341.123963. 
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The thienocarbazole 7 was isolated as a white solid (30.0 mg, 10%) with identical properties to 
those presented above. 
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